• Latest Posts

U.S. approval for psychedelic drug MDMA nears after success in clinic

Rebuilding relations: U.K. rejoins Horizon Europe to boost funding opportunities

Biogen acquiring Reata Pharmaceuticals for $7.3B

FDA grants breakthrough therapy designation to Duchenne muscular dystrophy treatment

Could a natural sweetener from hydrangeas treat Alzheimer’s disease?

New CHAIN Biotech funding to aid CADD therapeutic platform


Recbio shingles vaccine clinical trial approved 

Epsilogen completes first clinical trial of IgE antibody to treat cancer

Medicxi announces $400M fund for life science companies

Diabetes drug could promote healthy aging

Triastek sees positive results from printed oral treatment for ulcerative colitis

Can the microbiome help the fight against infections?